Use of combinatorial pharmacogenomic testing in two cases from community psychiatry
Eve S Fields,1 Raymond A Lorenz,2 Joel G Winner2 1Northwest Center for Community Mental Health, Reston, VA, USA; 2Assurex Health, Mason, OH, USA Abstract: This report describes two cases in which pharmacogenomic testing was utilized to guide medication selection for difficult to treat patients. The...
Saved in:
Main Authors: | Fields ES (Author), Lorenz RA (Author), Winner JG (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2016-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Canadian Medication Cost Savings Associated with Combinatorial Pharmacogenomic Guidance for Psychiatric Medications
by: Tanner JA, et al.
Published: (2019) -
Editorial: From Trial and Error to Individualised Pharmacogenomics-Based Pharmacotherapy in Psychiatry
by: R. van Westrhenen, et al.
Published: (2021) -
Two methods for determining combinatorial identities
by: Victor Kowalenko
Published: (2023) -
Are Community Pharmacists Ready to Deliver Pharmacogenomics Testing Services?
by: Heba Ghazal, et al.
Published: (2023) -
Combinatory Linguistics
by: Bozsahin, Cem
Published: (2012)